Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Not yet recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Conditions

Papillomavirus Infections 1Intestinal Neoplasms 1CIN 2/3 1

Interventions

Carboplatin 273Paclitaxel 267Gemcitabine 244Bevacizumab 226Cisplatin 218pembrolizumab 214Docetaxel 210Pemetrexed 162Capecitabine 148Fluorouracil 129Oxaliplatin 121Cyclophosphamide 121Nivolumab 112Dexamethasone 100Trastuzumab 89Leucovorin 87Cetuximab 85Rituximab 83Irinotecan 82Injections 81Erlotinib Hydrochloride 70Prednisone 68Doxorubicin 68Temozolomide 67atezolizumab 65Bortezomib 65Ipilimumab 64Fulvestrant 59Radiotherapy 54Drug Therapy 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Artesunate × Clear all
NCT07095309 2025-07-31

NeoART-M

Metanoic Health Ltd.

Phase 2 Not yet recruiting
120 enrolled

Intestinal Neoplasms

NCT07095478 2025-07-31

NeoART-CIN

Metanoic Health Ltd.

Phase 2 Not yet recruiting
28 enrolled

CIN 2/3

NCT05555862 2025-05-18

anal HSIL HIV-

Frantz Viral Therapeutics, LLC

Phase 2 Active not recruiting
17 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡